Royce & Associates’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-67,000
Closed -$4.51M 786
2025
Q4
$4.51M Sell
67,000
-7,028
-9% -$473K 0.05% 480
2025
Q3
$5.43M Sell
74,028
-13,001
-15% -$864K 0.05% 454
2025
Q2
$4.53M Sell
87,029
-119,612
-58% -$6.81M 0.05% 480
2025
Q1
$13.2M Buy
206,641
+9,642
+5% +$560K 0.14% 215
2024
Q4
$9.42M Buy
196,999
+72,988
+59% +$3.74M 0.09% 337
2024
Q3
$7.1M Sell
124,011
-52,716
-30% -$3.02M 0.06% 406
2024
Q2
$9.25M Sell
176,727
-14,828
-8% -$650K 0.09% 330
2024
Q1
$7.79M Buy
191,555
+52,245
+38% +$1.96M 0.07% 396
2023
Q4
$5.15M Buy
+139,310
New +$5.25M 0.05% 490
2023
Q2
Sell
-45,000
Closed -$1.72M 931
2023
Q1
$1.72M Sell
45,000
-51,000
-53% -$2.39M 0.02% 686
2022
Q4
$5.46M Hold
96,000
0.06% 443
2022
Q3
$3.8M Hold
96,000
0.04% 506
2022
Q2
$4.22M Buy
96,000
+64,000
+200% +$2.77M 0.04% 526
2022
Q1
$1.28M Buy
+32,000
New +$1.14M 0.01% 780
2014
Q3
Sell
-1,200
Closed -$12K 1415
2014
Q2
$12K Sell
1,200
-64,875
-98% -$550K ﹤0.01% 1417
2014
Q1
$839K Sell
66,075
-46,622
-41% -$692K ﹤0.01% 1170
2013
Q4
$1.69M Sell
112,697
-35,000
-24% -$450K ﹤0.01% 1097
2013
Q3
$1.63M Buy
147,697
+64,075
+77% +$534K ﹤0.01% 1106
2013
Q2
$664K Buy
+83,622
New +$533K ﹤0.01% 1203

Other funds holding HALO